• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者腹部腹水的预防和治疗干预措施:随机对照试验的系统评价

Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials.

作者信息

Çelik Ferya, Bektaş Hicran

机构信息

Department of Internal Medicine Nursing, Akdeniz University Faculty of Nursing, Antalya, Turkey.

出版信息

Florence Nightingale J Nurs. 2021 Jun 1;29(2):250-262. doi: 10.5152/FNJN.2021.19171. eCollection 2021 Jun.

DOI:10.5152/FNJN.2021.19171
PMID:34263244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8245014/
Abstract

AIM

This systematic review aimed to evaluate the efficacy of preventive and therapeutic approaches used in the management of ascites in liver cirrhosis.

METHOD

Literature review was done in "Scopus, Web of Science, CINAHL, ScienceDirect, PubMed MEDLINE, Ulakbim National Database, and Cochrane Library" databases using the keywords, "ascites, refractory ascites, liver cirrhosis, intervention, prophylaxis, treatment, nursing management, prevention, ascites management, randomized controlled trials," and 2,447 articles were obtained. The studies with low bias risk were included. This systematic review was planned by following the recommendations of the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement.

RESULTS

A total of 11 randomized controlled trials were included. When the included studies were examined, ascites treatment approaches were evaluated in all of the studies; however, preventive approaches were not evaluated. It was found that mannitol, a diuretic drug, helps ascites management by contributing to weight loss, decrease in abdominal circumference, and urinary sodium excretion. The automatic low-flow ascites pump also reduced the need for large-volume paracentesis. There was a decrease in weight and abdominal circumference measurements when band compression was applied to the umbilicus.

CONCLUSION

Therapeutic approaches were found to be effective. It was thought that the lack of nursing practices and the prevention of ascites formation in the abdomen was an important deficiency. Randomized controlled trials were recommended for the prevention of abdominal ascites formation and the side effects of treatment on the patient.

摘要

目的

本系统评价旨在评估用于肝硬化腹水管理的预防和治疗方法的疗效。

方法

在“Scopus、科学网、护理学与健康领域数据库、ScienceDirect、PubMed MEDLINE、Ulakbim国家数据库和Cochrane图书馆”数据库中进行文献检索,使用关键词“腹水、顽固性腹水、肝硬化、干预、预防、治疗、护理管理、预防、腹水管理、随机对照试验”,共获得2447篇文章。纳入偏倚风险低的研究。本系统评价按照2015年系统评价与Meta分析方案优先报告条目(PRISMA-P)声明的建议进行规划。

结果

共纳入11项随机对照试验。在检查纳入的研究时,所有研究均评估了腹水治疗方法;然而,未评估预防方法。发现利尿剂甘露醇通过促进体重减轻、腹围减小和尿钠排泄有助于腹水管理。自动低流量腹水泵也减少了大量腹腔穿刺放液的需求。当对脐部进行束带压迫时,体重和腹围测量值有所下降。

结论

发现治疗方法有效。认为缺乏护理措施以及预防腹部腹水形成是一个重要缺陷。建议进行随机对照试验以预防腹部腹水形成及治疗对患者的副作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a62e/8245014/8bf16f624844/FNJN-29-2-250-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a62e/8245014/23c95d474405/FNJN-29-2-250-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a62e/8245014/8bf16f624844/FNJN-29-2-250-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a62e/8245014/23c95d474405/FNJN-29-2-250-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a62e/8245014/8bf16f624844/FNJN-29-2-250-g02.jpg

相似文献

1
Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials.肝硬化患者腹部腹水的预防和治疗干预措施:随机对照试验的系统评价
Florence Nightingale J Nurs. 2021 Jun 1;29(2):250-262. doi: 10.5152/FNJN.2021.19171. eCollection 2021 Jun.
2
Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.失代偿期肝硬化成人腹水的治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 16;1(1):CD013123. doi: 10.1002/14651858.CD013123.pub2.
3
Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta-analysis.米多君对肝硬化腹水患者的影响:系统评价与荟萃分析。
J Dig Dis. 2016 Jan;17(1):11-9. doi: 10.1111/1751-2980.12304.
4
Sodium restriction in patients with cirrhotic ascites: a protocol for a systematic review.肝硬化腹水患者的钠限制:一项系统评价方案
Syst Rev. 2016 May 10;5:78. doi: 10.1186/s13643-016-0250-4.
5
Systematic review with meta-analysis: automated low-flow ascites pump therapy for refractory ascites.系统评价与荟萃分析:自动化低流量腹水泵治疗难治性腹水。
Aliment Pharmacol Ther. 2019 Nov;50(9):978-987. doi: 10.1111/apt.15502. Epub 2019 Oct 3.
6
Nonselective β-Blockers and Survival in Patients With Cirrhosis and Ascites: A Systematic Review and Meta-analysis.非选择性β受体阻滞剂与肝硬化伴腹水患者生存:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2016 Aug;14(8):1096-1104.e9. doi: 10.1016/j.cgh.2016.01.012. Epub 2016 Jan 30.
7
TIPS versus paracentesis for cirrhotic patients with refractory ascites.经颈静脉肝内门体分流术(TIPS)与腹腔穿刺术治疗肝硬化难治性腹水的比较
Cochrane Database Syst Rev. 2004(3):CD004889. doi: 10.1002/14651858.CD004889.
8
Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.特利加压素在肝硬化伴腹水且无肝肾综合征患者中的作用:当前证据的系统评价。
Can J Gastroenterol Hepatol. 2020 Jun 22;2020:5106958. doi: 10.1155/2020/5106958. eCollection 2020.
9
What is the effectiveness of the negative pressure wound therapy (NPWT) in patients treated with open abdomen technique? A systematic review and meta-analysis.负压伤口治疗(NPWT)在接受开放腹部技术治疗的患者中的有效性如何?一项系统评价和荟萃分析。
J Trauma Acute Care Surg. 2016 Sep;81(3):575-84. doi: 10.1097/TA.0000000000001126.
10
Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.肝硬化伴利尿剂抵抗性腹水患者对单次大量腹腔穿刺放液的心血管、肾脏及神经体液反应
Am J Gastroenterol. 1997 Mar;92(3):394-9.

本文引用的文献

1
Predictors of 1-month and 3-months Hospital Readmissions in Decompensated Cirrhosis: A Prospective Study in a Large Asian Cohort.失代偿期肝硬化 1 个月和 3 个月再住院的预测因素:一项大型亚洲队列的前瞻性研究。
Ann Hepatol. 2019 Jan-Feb;18(1):30-39. doi: 10.5604/01.3001.0012.7859.
2
Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States.美国肝硬化患者再住院的全国估计数和危险因素。
Liver Int. 2019 May;39(5):878-884. doi: 10.1111/liv.14054. Epub 2019 Feb 25.
3
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
失代偿期肝硬化患者长期白蛋白治疗(ANSWER):一项开放标签随机试验。
Lancet. 2018 Jun 16;391(10138):2417-2429. doi: 10.1016/S0140-6736(18)30840-7. Epub 2018 Jun 1.
4
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.欧洲肝脏研究学会失代偿期肝硬化患者管理临床实践指南
J Hepatol. 2018 Aug;69(2):406-460. doi: 10.1016/j.jhep.2018.03.024. Epub 2018 Apr 10.
5
Current management of refractory ascites in patients with cirrhosis.肝硬化患者难治性腹水的当前管理。
J Int Med Res. 2018 Mar;46(3):1138-1145. doi: 10.1177/0300060517735231. Epub 2017 Dec 6.
6
Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.Alfapump® 系统与大量腹腔穿刺放液治疗难治性腹水的比较:一项多中心随机对照研究。
J Hepatol. 2017 Nov;67(5):940-949. doi: 10.1016/j.jhep.2017.06.010. Epub 2017 Jun 21.
7
Nursing care of patients with chronic liver diseases: Time for action.慢性肝病患者的护理:行动时刻。
J Adv Nurs. 2018 Mar;74(3):498-500. doi: 10.1111/jan.13350. Epub 2017 Jul 5.
8
Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases.同种异体间充质干细胞移植治疗自身免疫性疾病所致肝硬化的效果
Int J Rheum Dis. 2017 Sep;20(9):1219-1226. doi: 10.1111/1756-185X.13015. Epub 2017 Feb 20.
9
Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites.用于治疗肝硬化难治性腹水患者的自动低流量腹水泵
Therap Adv Gastroenterol. 2017 Feb;10(2):283-292. doi: 10.1177/1756283X16684688. Epub 2017 Jan 5.
10
Strategies to Reduce 30-Day Readmissions in Patients with Cirrhosis.降低肝硬化患者30天再入院率的策略。
Curr Gastroenterol Rep. 2017 Jan;19(1):1. doi: 10.1007/s11894-017-0543-3.